HIGHLIGHTS
- who: Bingwu Wang from the Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China Full list of author information is available at the end of the article , have published the article: Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway, in the Journal: (JOURNAL)
- what: The authors reported the identification of compound S9, an RPL11-mimicking p53 agonist. The authors seek to find a small_molecule RPL11 mimetics by using molecular docking-based virtual screening to identify . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.